Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.

A new study reveals that Epstein-Barr virus (EBV) infection exacerbates ulcerative colitis (UC) by driving macrophage ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Scientists at the University of Virginia School of Medicine have uncovered a key reason why some people continue to ...

Self-powered microneedle patches generate hydrogen, microcurrents, and magnesium ions to repair UV-damaged skin, reduce ...

A discovery about how severe COVID-19 damages lung cells suggests that an existing drug could treat lingering respiratory ...

Scientists have learned more about how SARS-CoV-2 infections, which cause COVID-19, can ruin the ability of immune cells to ...

Here are five recent innovative bioprinting and bioink studies that are building synthetic biological structures.

Changes in the cellular response during lung damage caused by SARS-CoV-2 – the virus behind COVID-19 – have been uncovered. Researchers reveal distinct phases where waves of immune responses give way ...

Preservation of Skeletal Muscle Function Shown Over 3 Years Resulting in 52% Slowing of Disease----Data Presented at the 2025 Muscular ...

Measles is known for its characteristic rash, but it can have serious respiratory and neurologic complications.